Economic analysis of community pharmacists providing influenza vaccination in Ontario
Author(s): ,
Daria O'Reilly
Affiliations:
MSc PhD
,
Gord Blackhouse
Affiliations:
MBA MSc
,
Sheri Burns
Affiliations:
BA
,
Jim Bowen
Affiliations:
BScPharm MSc
,
Natasha Burke
Affiliations:
MSc
,
Jeff Mehltretter
Affiliations:
BSc
Nancy Waite
Affiliations:
PharmD
Canadian Pharmacists Conference ePoster Library. Houle S. Jun 3, 2017; 174246
Dr. Sherilyn Houle
Dr. Sherilyn Houle
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)

Objectives
In 2012, Ontario pharmacists were authorized to administer influenza vaccines to individuals 5 years of age and older. Little is known on the economic impact of allowing pharmacists to vaccinate against influenza. The aim of this study was to conduct a pre-post comparison of the healthcare resource use and indirect costs associated with this legislative change, from 2011/12 to 2013/14. The Ministry of Health perspective was applied to estimates of direct healthcare costs, and the societal perspective was applied to indirect healthcare cost estimates.

Methods
Changes in vaccination rates were determined from administrative data. Efficacy of the vaccine, rates of physician and emergency department visits, hospitalizations, and lost productivity due to illness from influenza or obtaining the vaccine in different settings were obtained from the literature. Program costs considered both vaccine costs and professional fees.

Results
A net increase of 448,000 vaccinations was realized after pharmacies participated in influenza immunization. A cost to the health system of approximately $6.3 million was incurred from these additional vaccinations, and a savings of $763,000 in direct healthcare costs was estimated, as the population vaccinated in pharmacies tended to be younger and healthier individuals. From a societal perspective, up to $4.5 million in lost productivity was saved as a result of workers not having to take time off to obtain the vaccine at community pharmacies (highlighting their greater accessibility and longer operating hours) compared to other settings, and an additional $3.4 million was saved from reduced absenteeism due to influenza illness.

Conclusion
The convenience of pharmacy-based vaccination rates among younger and healthier patients is estimated to result in savings from both direct and indirect/productivity costs. As this population of working adults are frequently caregivers for children or aging parents, vaccination of this hard-to-reach demographic is also expected to further reduce flu transmission to these more vulnerable populations.

    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings